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Summary 
Brown-Norway (BN) rats injected with HgC12 develop a systemic autoimmune disease associated 
with a polyclonal B cell activation, due to autoreactive T cells specific for self-class II molecules, 
while Lewis  (LEW)  rats  injected with  HgCI2 do not  exhibit  autoimmunity and develop a 
non-antigen-specific, CD8-mediated immunosuppression assessed  by a depression of T cell functions, 
and  a  protection  against  experimental autoimmune encephalomyelitis (EAE).  Resistance  to 
HgC12-induced autoimmunity is not due to these suppressor cells since treatment with an anti- 
CD8  monoclonal antibody  (mAb)  did  not  allow autoimmunity to  appear.  The  absence of 
autoimmunity in this strain could result from the absence of autoreactive T cells, or from quantitative 
or qualitative differences of these cells between susceptible and resistant strains.  In the present 
study, we show that CD4 + anti-class IIT ceils are present in HgC12-injected LEW rats and 
are as frequent as in BN rats when assessed by limiting dilution analysis. LEW CD4 + autore- 
active T  cell lines were derived. They proliferated in the presence of normal class II-bearing 
cells, secreted interleukin 2,  and did not induce B cells to produce immunoglobulins. Transfer 
of one of these lines, LEW Hg A, into normal LEW rats led to the appearance of CD8 + cells 
responsible for a non-antigen-specific immunosuppression that induced complete protection from 
EAE.  Immunosuppression was  abrogated after treatment with  an anti-CD8  mAb.  In vitro, 
CD8 + ceUs from rats injected with the LEW Hg A T  cell line proliferated in the presence of 
activated T  cells whatever their origin.  We conclude that HgC12 induces CD4 + autoreactive 
T cells that proliferate in the presence of class II + cells in susceptible BN as well as in resistant 
LEW rats.  But while these cells collaborate with B ceils to produce autoantibodies in BN rats, 
they initiate in LEW rats a suppressor circuit involving antiergotypic CD8 + suppressor cells. 
B 
rown-Norway (BN) 1 rats injected with HgC12 develop 
lupus-like systemic autoimmune disease in the context 
of a polyclonal B cell activation (1, 2),  due to autoreactive 
T cells specific for self-class II molecules (3). In contrast, Lewis 
(LEW) rats injected with HgC12 do not develop autoimmu- 
nity but exhibit a non-antigen specific CD8-mediated im- 
munosuppression (4). This immunosuppression is mediated 
by non-antigen-specific CD8 + cells responsible for depres- 
sion of T  cell functions (4).  HgCl2-injected LEW rats are 
protected against Heymann's nephritis (5) and experimental 
autoimmune encephalomyelitis (EAE) (6,  7).  Protection is 
I Abbreviations used in this paper: BN, Brown-Norway; BP, myelin basic 
protein; EAE, experimental autoimmune encephalomyelitis; LDA, limiting 
dilution  analysis; LEW, Lewis; PPD, purified protein  derivative. 
not absolute, probably due to the emergence of contrasup- 
pressor ceils (7).  Until now, the way these suppressor cells 
were induced  and  their  specificity were unknown.  Since 
anti-class IIT cells were present in BN rats injected with 
HgCI2 (3) and since in another situation anti-class IIT ceils 
have been shown to induce suppressor cells (8), it was tempting 
to look for the presence of anti-class IIT cells in HgC12- 
injected LEW rats and to assess their possible connection with 
the mercury-induced suppressor cells observed in that strain. 
We show here that anti-class IIT cells are detectable in 
LEW rats injected with HgC12, with a frequency similar to 
that found in susceptible BN rats. Autoreactive anti-class II 
CD4 + T  cell lines have been derived from LEW rats in- 
jected with HgC12.  One of these lines has been transferred 
in naive LEW rats and it acted as a suppressor inducer line. 
It triggered the appearance of CD8 + antiergotypic and per- 
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II T  cells differed from those found in HgC12-injected BN 
rats by their  inability to help in vitro or in vivo B cells to 
produce antibodies. 
Materials  and Methods 
Rats.  LEW and BN rats were initially obtained from the Centre 
de Selection et d'Elevage des Animaux de Laboratoire  (Orl~ans-La 
Source,  France),  and  spontaneously hypertensive  rats  from  Iffa 
Credo  (Lyon,  France).  These  strains  were  then  maintained  by 
brother-sister  mating in our facilities. 8-12-wk-old males were used. 
Antigens.  Myelin and myelin basic protein (BP) were prepared 
as described elsewhere (6). Purified protein derivative (PPD) from 
Mycobacterium tuberculosis  was obtained from Statens (Serum Institut, 
Copenhagen, Denmark). OVA was obtained from Sigma Chem- 
ical Co. (St.  Louis,  MO). 
Injections of HgCl2, Immunization with OVA, and EAE Induction. 
HgC12 was  subcutaneously injected  at  a dose  of 100/~g/100 g 
body weight, three times a week, as described elsewhere (1). LEW 
rats were immunized with 100/~g of OVA (Sigma Chemical Co.) 
emulsified in CFA in the rear footpads and killed after 10 d. EAE 
was induced as described (5). Briefly, myelin was suspended in PBS 
at  a concentration of 10 mg/ml; the solution was emulsified  in 
an  equal  volume of CFA containing 0.2  mg/ml M.  tuberculosis 
(H-37RA; Difco Laboratories, Detroit, MI); 0.25 ml of this emul- 
sion  was injected  subcutaneously in the two rear footpads. 
mAbs and FACScan|  Analysis.  W3/13, W3/25, OX8, OX39, 
OX6, OX17, and OX22 mAbs were initially  obtained from the 
Public Health Laboratory Service collection  (Oxford, UK) as cells. 
Ascites and purified antibodies were prepared as described (9). They 
recognize,  respectively,  all T  cells (10), CD4 § (11), CD8"  (11), 
Ib2R*  cells (12), MHC class IIIA molecules  (13), MHC class 
II IE molecules (14), and CD45R molecules (15). MARK-1 (mouse 
anti-rat g light chain) mAb was kindly provided by H. Bazin (Lou- 
vain,  Belgium).  B10H2,  a mouse anti-thyroglobulin IgGl mAb 
was kindly provided  by Dr.  D.  Glotz (H6pital  Broussais,  Paris, 
France), and was used as an irrelevant mAb. Cells to be tested were 
stained by indirect immunofluorescence  with a fluoresceinated goat 
F(ab')2 anti-mouse Ig antibody (Caltag,  San Francisco,  CA) ad- 
sorbed on normal rat serum. All antibodies were used 1:100 diluted. 
The cells were analyzed with a FACScan  |  (Becton Dickinson & 
Co., Sunnyvale,  CA); a minimum of 10,000 cells were counted. 
Serum IgE Concentration and Renal Immunofluorescence.  Serum 
IgE concentration was  determined by ELISA as described  else- 
where (16), and Ig deposits  in the glomeruli were looked for as 
previously  (1). 
Cell Culture Medium.  Culture medium was RPMI 1640 (Ser- 
omed, Berlin, Germany) supplemented  with penicillin (100 U/ml; 
Gibco, Paisley, UK), streptomycin  (100/zg/ml), nonessential amino 
acids (0.1 mM), t-glutamine (2 raM),  sodium pyruvate (1 raM; 
Biochrom KG,  Berlin,  Germany),  2-ME  (2  x  10 -5  M;  Sigma 
Chemical Co.), and 2% heat-inactivated  normal rat serum or 10% 
in the case of limiting dilution analysis (LDA). 
Limiting Dilution Analysis.  T cell subsets and B cells were purified 
by panning (3). The purity of CD4+, Ig+, and CD8 § cells was 
assessed as described  (3),  and was found to be 97,  80,  and 98% 
respectively. LDA was performed as described elsewhere (3). Briefly, 
CD4 § or CDS" T cells from LEW rats injected with HgC12 for 
4,  6,  14, or 30 d were cultured at  an input  from 1,000-80,000 
cells/well  in culture medium supplemented  with 15% Con A su- 
pernatant obtained from rat spleen cells as described elsewhere (3), 
in the presence of normal or autologous 3,000-rad irradiated  T- or 
B-enriched  cells as stimulator cells. 24 wells were seeded for each 
cell concentration.  Cultures were performed in 96-well U-bottomed 
microtiter plates  (Nunc,  Kamstrup,  Denmark)  for 7 d in a 6% 
CO2 incubator.  [3H]Thymidine was added 24 h before the end of 
the culture.  Background values were obtained by omitting stimu- 
lator cells in the culture.  A culture was considered  positive when 
the number of  counts per minute was superior to mean background 
plus 3 SD. In some experiments,  stimulator cells were preincubated 
with the OX6, OX17, W3/25 or OX8 mAbs (50/zg/ml) for 90 
min at 4~  and washed before use. The frequency of negative wells 
for each cell concentration was semilogarithmatically  plotted as a 
function of the number of cells/well.  Experimental  results  were 
analyzed according to Taswell (17), and were shown to fit a single- 
hit Poisson's distribution, at least for the initial part of the curves. 
Results were expressed as the mean reciprocal frequencies obtained 
from six rats  on each day. 
Proliferative Responses of CD8 + Cells  from LEW Rats Injected with 
HgCI2.  Purified CD8 + cells (2  x  10S/well) from normal LEW 
rats  or from LEW rats  injected  with  HgC12 for 7,  14,  or 30 d 
were cultured in culture medium supplemented  with 3% Con A 
supernatant alone, or in the presence of 2  x  101 irradiated  (3,000 
tad) CD4 § or CD8 § cells from normal or autologous rats, in 96- 
well flat-bottomed microculture plates (Costar,  Cambridge, MA) 
for  4  d.  [3H]Thymidine  (1  Ci/mmol  =  37  GBq/mmol;  0.4 
#Ci/well) (Dositek, Saclay, France) was added 24 h before the end 
of the culture.  Thymidine uptake was measured  as described else- 
where (3).  The results  were expressed  as cpm [3H]TdR. 
Preparation of TCettLines.  T cell lines were obtained from LEW 
rats  injected  with HgCI2 for 7 d by culturing 0.5  x  106 lymph 
node cells in 96-well U-bottomed microtiter plates  (Nunc), in a 
6% CO2 incubator in the presence of normal irradiated (3,000 tad) 
syngeneic  thymocytes (5-10  x  10Vml),  under a volume of 0.2 
ml/well  in  culture medium without Con A  supernatant.  After 
4-6 d, half of the medium was removed and replaced by culture 
medium containing 10%  Con A  supernatant.  7-10 d later, cells 
were stimulated again with thymocytes. Exactly the same proce- 
dure was  then followed  after  this  second  round of stimulation. 
To obtain an anti-OVA T cell line (LEW OVA), LEW rats were 
immunized with  100 #g OVA,  and  10 d later  lymph node cells 
were stimulated in the presence OVA (50/zg/ml). Con A superna- 
rant was added after 4-6 d as described above, and a second round 
of antigenic stimulation was performed 10 d later  exactly as the 
first one. The culture was maintained  on a basis of one stimulation 
every 2 wk. Phenotype of the cells was assessed after three,  five, 
and eight stimulations. 
Proliferative Response of T  Cell Lines.  T  cell  lines  from  the 
HgC12-injected rats were cultured (5  x  104 cells under a volume 
of 200/A) in 96-well flat-bottomed microculture plates (Costar), 
alone or in the presence of various stimulator cells (5  x  106/ml) 
for 3 d. In some experiments,  stimulator cells were preincubated 
with various mAbs (50/zg/ml) as described in LDA experiments. 
The proliferative  response  of the LEW OVA T cell line was as- 
sessed by culturing  5  x  104 cells in  the  presence  of irradiated 
(3,000  rad) syngeneic thymocytes (10S/ral) and OVA (50/~g/ml) 
for 3 d. 24 h before the end of the culture, cultures were pulsed 
with  1 #Ci  [3H]thymidine/well  and processed  as described  (3). 
Results  were expressed  as cpm [3H]TdR. 
Titration of  lL2 in Culture Supernatants.  Supernatants  were col- 
lected after 3 d of culture and assayed 1:4 diluted  on triplicate  cul- 
tures  of 104 IL-2-dependent  mouse CTLL-2 cells per well,  in 96- 
well flat-bottomed microculture plates. The CTLL-2 cultures were 
incubated for 24 h, pulsed during the last  12 h with [3H]thymi- 
dine, and processed as above. Human rIL-2 (Cetus Corp., Emeryville, 
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[3H]TdR. 
Ig Production In  Vitro.  Unseparated spleen  cells from normal 
LEW rats were layered over FicoU-Hypaque and RBC were elimi- 
nated by density centrifugation.  Cocultures  were performed by 
adding 5  x  104 purified T cells, preactivated by autologous APC 
for 3 d, to 2  x  10  s spleen cells under a final volume of 0.2 ml/well 
in 96-well flat-bottomed microculture plates for 12 d. T ceils alone 
and spleen cells alone were cultured as controls. 12 replicate wells 
of each culture combination were set up. 3 d after the beginning 
of the culture, 100/~1 of supernatant medium was removed in each 
well, and was replaced by fresh medium containing 3%  Con A 
supernatant as a source of IL-2. At the end of the culture,  super- 
natants were removed, pooled, and assayed for Ig production by 
ELISA (18). 
TranfferExwtiments.  LEW rats were intravenously injected with 
5  ￿  107 cells from one of the T  cell lines (LEW Hg A) derived 
from HgClz-injected LEW rats or from the LEW OVA T  cell 
line, and simultaneously immunized with myelin. Rats transferred 
with T cells were intraperitoneally injected or not with the OX8 
anti-CD8 or B10H2 mAbs as irrelevant mAbs (0.5 mg/rat per in- 
jection on days 0, 10, and 19). It was verified at the time of death 
that OX8-injected rats were depleted of CD8 + cells (3 %  of lymph 
node cells expressed CD8 molecules vs. 18% in LEW rats injected 
with B10-H2 mAb). Rats have also been transferred with 5  x  107 
LEW OVA cells cultured for 3 d with BP (50/.tg/ml) or with the 
same number of thymocytes cultured in the presence of BP in the 
same conditions. Rats were examined daily to assess neurological 
manifestations. These manifestations were scored on a 0-4 scale: 
0, no clinical signs;  1, flaccid tail; 2, ataxia; 3, hind limb paralysis; 
and 4,  moribund or dead (6,  7). 
Rats were killed on day 21 because paralyzed rats recover at that 
time. Lymph node cells were prepared as described (2).  Cells (2 
x  10S/well) were cultured alone, in the presence of Con A (2.5 
#g/ml) for 2 d, in  the presence of irradiated  (3,000 rad) lymph 
node cells from normal BN rats (106/ml)  for 4 d, or in the pres- 
ence of BP or PPD (50/~g/ml) for 3 d. Various numbers of lymph 
node cells from rats transferred with LEW Hg A cells were added 
at the beginning of the culture, and the percentage of inhibition 
of the proliferative response was calculated. 
The proliferative response was also performed in the presence 
of 2  x  10  s irradiated (3,000 rad) LEW Hg A or LEW OVA cells, 
previously activated or not, or in the presence of 20% supernatant 
obtained after culturing the lines for 3 d in the presence of their 
antigen, or in the presence of 20% Con A supernatant. Cells were 
cultured  for 4  d  in  96-well  flat-bottomed microculture  plates. 
[3H]Thymidine was added 24 h before the end of the culture, and 
thymidine uptake was measured as described above. 
The occurrence of manifestations similar to those triggered by 
HgC12 in BN rats were looked for in the different  groups by mea- 
suring serum IgE concentration every 1 wk until death, and by 
examining kidneys at  the time of death  for the presence of Ig 
deposits. 
Statistical Analysis.  Data were compared by using Student's t 
or nonparametric Mann Whitney or Wilcoxon tests. 
Results 
Autoreactive Anti-class  II T Cells Are Present in LEW Rats 
Injected with  HgCI2.  CD4 §  T  cells  obtained  from  LEW 
rats injected with  HgC12 for 4,  6,  14,  or 30 d  proliferated 
in the presence of syngeneic B-enriched cells. The frequen- 
cies of these autoreactive T cells were not statistically different 
between days 4 and 30 (Fig.  1).  Mean reciprocal frequencies 
ofautoreactive T  cells were 34.0  _+  10.3, 24.2  _+  12.5,  16.0 
_+  4.8,  and  22.2  +_  3.3  x  103,  at  days 4,  6,  14,  and  30, 
respectively (Fig. 1). The ability of B-enriched cells to stimulate 
autoreactive  T  cells  was  similar  whether  they  came  from 
normal LEW rats or from autologous rats exposed to HgC12 
(Fig.  1).  T  cells did not  respond when B  cells were prein- 
cubated with the OX6 anti-class II IA mAb (Fig.  1). Prein- 
cubation of B cells with the anti-class II IE, the anti-CD4, 
or the anti-CD8 mAbs did not modify the frequency of au- 
toreactive  T  cells  (not  shown).  Normal  or  autologous  T 
cells were unable to act as stimulator  cells (Fig.  1).  CD4 § 
T  cells from normal LEW rats did not  respond to autolo- 
gous B cells (Fig.  1) showing that,  within the limits of the 
method, autologous mixed lymphocyte reaction was not ob- 
served in  normal rats. 
CD8 + Cells from LEW Rats Injected with HgCb Proliferate 
in the Presence of Autologous CD4 + Cells.  Since non-anti- 
gen-specific CD8 + suppressor cells and autoreactive CD4 + 
cells were found concomitantly in LEW rats injected with 
HgC12,  a  connection  between  these  two  populations  was 
sought.  To  test  whether  CD8 §  cells  were  stimulated  by 
HgC12-activated CD4 + T  cells, purified CD8 + lymph node 
cells from LEW rats injected with HgC12 were cultured  in 
the presence of irradiated autologous purified CD4 + cells or 
in  the  presence  of  CD4 +  cells  from  normal  LEW  rats. 
CD8 §  cells  from LEW  rats  injected  with  HgCI2 for 7  d 
proliferated  in  the  presence of autologous  CD4 §  cells but 
not in the presence of CD4 + cells from normal LEW rats 
(Fig. 2) or CD8 § cells whether they originated from normal 
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Figure  1.  Mean reciprocal frequencies of autoreactive anti-class  II 
CD4 + T cells in HgClz-injected LEW rats. CD4 + T cells from rats in- 
jected with HgCI2 for 4, 6, 14, and 30 d were cultured in the presence 
of syngeneic B cells from autologous (.) or normal ([]) rats, or of syn- 
geneic T cells from autologous (Q) or normal (O) rats. B cells pretreated 
with the OX6 mAb were also used as stimulator cells; they were obtained 
either from autologous (~) or from normal (~  rats. CD4 + T cells from 
LEW rats injected with the control solution were cultured in the presence 
of normal syngeneic spleen cells (D). 
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Figure  2.  Proliferative response of CD8 + lymph node cells from LEW 
rats injected with HgC12 for 7 (Hg7) or 14 d (Hg14) in the presence of 
irradiated CD4 + cells  from normal (n  o or HgC12-injected (Hg7 or Hg14) 
rats.  Results  are mean  of five experiments. 
Table  1.  IL-2 Production by LEW Hg and LEW OVA 
T  Cell Lines 
CTLL-2  Supernatant  from:  cpm 
+  -  310  _+  115 
+  LEW  Hg A  18,795  _+  380* 
+  LEW  Hg B  15,425  +  875* 
+  LEW Hg C  14,695  _+  1,218" 
+  LEW  OVA  17,880  _+  1,112" 
+  rlL-2*  26,545  +  9,754* 
Supernatant  from T cell lines was added to CTLL-2 cells, and thymidine 
incorporation was  measured  after  24 h. 
p  <  0.001  when compared  with control culture. 
* rlL-2 was  added at  a concentration  of 5 U/ml. 
or  autologous  rats  (not  shown).  The  mean  reciprocal 
frequency of these CD8 § cells was 45  _+  12  x  103. CD8 + 
cells from LEW rats injected with HgC12 for 14 (Fig.  2) or 
30 d  (not  shown) were unable to proliferate whatever the 
stimulator cells tested, although the increase  in the number 
of CD8 + cells was still observed (not shown) as previously 
reported  (4). 
Characterization of Autoreactive T  Cell Lines Derived  from 
LEW Rats Injected witk HgCI2.  We have studied the pos- 
sibility that cells activating the CD8 + suppressor cells were 
HgC12-induced autoreactive anti-class II T cells. To test this 
hypothesis,  we  developed  autoreactive  T  cell  lines  from 
HgC12-treated  LEW  rats.  Seven  autoreactive  T  cell  lines 
were derived from seven rats  (LEW Hg A  through  LEW 
Hg G). After three stimulations,  all the lines had the same 
phenotype,  i.e.,  W3/13 +  CD4 +  CDS-  Ig-  CD45R-IL- 
2R +.  This phenotype remained  stable after  10 mo of cul- 
ture.  These cell lines produced II-2 after stimulation  with 
irradiated  syngeneic thymocytes (Table  1; and not shown). 
As a control, a T cell line was obtained from LEW rats im- 
munized with OVA (LEW OVA) that had the same pheno- 
type and also produced IL-2 when stimulated with OVA (Table 
1). Fig. 3 a shows the proliferative response of LEW Hg A 
cells in the presence of various stimulator cells. They prolifer- 
ated in the presence of LEW syngeneic thymocytes, but not 
in the presence of allogeneic BN or SHR thymocytes. The 
response was completely abolished when the stimulator cells 
were preincubated with an anti-class II IA mAb (OX6), while 
the response was not modified when the stimulator cells were 
preincubated with  an anti-class  II IE (OX17) or with  the 
other IgG1 mAbs (W3/25  or OX8;  not shown).  Normal 
syngeneic spleen cells were also efficient at stimulating this 
T  cell line,  and preincubation with the OX6 mAb also in- 
hibited the T cell response (not shown). Similar results were 
obtained with the other LEW Hg lines (not shown).  This 
suggests that the LEW Hg T  cell lines recognize either IA 
class II molecules or a self-peptide in the context of IA class 
II molecules.  As shown in Fig. 3 b, LEW OVA T cells prolifer- 
ated in the presence of OVA, and this proliferative response 
was completely abolished when cultures were performed with 
stimulator cells preincubated with the anti-class II OX6 mAb, 
suggesting that the LEW OVA T cell line recognizes a pep- 
tide derived from OVA in the context of class II molecules. 
Anti-class II T  Cell Lines Are  Unable to Provide B  Cell 
Help  LEW Hg A, B, and C lines were tested for their ability 
to trigger B cell differentiation.  The addition of LEW Hg 
A T  cells to syngeneic spleen cells as a source of B cells did 
not modify the baseline production of Ig by these cells (Ig 
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Specificity of the LEW Hg A T cell line. (a) Proliferative 
response of LEW Fig A T cells cultured alone (I)  or in the presence 
of APC (I-l). Cultures were also performed in the presence of syngeneic 
APC preincubated with the OX6, anti-class II IA, or the OX17, anti-class 
II IE mAb. (b) Proliferative response of LEW OVA T cells cultured alone 
(11), in the presence of APC (O), or in the presence of OVA (50/tg/ml) 
and APC ([~), preincubated or not with the OX6 mAb. Results are the 
mean of five experiments. 
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ng/ml in cultures containing spleen cells only). Similar results 
were obtained with LEW Hg B and C  T  cells. 
All seven attempts to derive autoreactive anti-class II T 
cell lines from normal LEW rats failed. This might be related 
to the very low frequency of such cells in normal rats as shown 
by LDA. 
The Autoreactive Anti-class II LEW Hg A  T Cell Line Pro- 
tects LEW Rats from EAE.  It has been previously shown 
that HgC12oinduced CD8 § suppressor cells were able to pro- 
tect LEW rats from the appearance of autoimmune diseases 
such as EAE (7).  To test the role of anti-class II T  cells in 
the initiation of the suppressor  circuit, we transferred the 
LEW Hg A T cell line in rats immunized with myelin. As 
shown in Table 2, all the LEW rats immunized with myelin 
developed a severe EAE, while the immunized rats transferred 
with preactivated LEW Hg A cells were protected.  Rats were 
not protected when they received nonactivated LEW Hg A 
T cells. The protection was completely abolished after treat- 
ment of the recipients with the OX8 anti-CD8 mAb. Injec- 
tions of the irrelevant B10-H2 mAb did not abrogate LEW 
Hg A-mediated suppression  (Table 2). LEW OVA cells had 
no effect on the course of EAE whether they were cultured 
in the presence  of OVA or BP before transfer.  Injection of 
thymocytes alone cultured in the presence of BP did not pro- 
tect recipients from EAE (Table 2), showing that LEW Hg 
A-induced  suppression  was  not  due  to  contaminating 
thymocytes. 
The Autoreactive Anti-class II LEW Hg A  T Cell Line Triggers 
Non-Antigen-specific  CD8 + Suppressor Cells.  Responses to 
BP or PPD, but also to the Con A mitogen or to allogeneic 
antigens of lymph node cells from rats transferred with the 
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Figure  4.  Non-antigen-specific,  CD8-dependent immunosuppression 
induced by transfer of the LEW Hg A T cell line in normal LEW rats. 
Proliferative responses to BP (a), PPD (b), Con A (c), or lymph node cells 
from BN rats as an alloantigen  (d) of lymph node cells from LEW rats. 
LEW rats were normal (I-1), immunized with myelin ([]), immunized 
with myelin and transferred with 5  x  10  ? LEW Hg A T cells whether 
they were treated with an anti-CD8 mAb (I), an irrelevant mAb (11), 
or not (m), or immunized with myelin and transferred  with 5  x  10  ? 
LEW OVA T cells preactiwted with OVA ([]) or BP (11). Stimulation 
index  -  cpm of stimulated  cells/cpm  of unstimulated  cells. Results  are 
mean of six experiments. 
LEW Hg A T cell line, were inhibited when compared with 
the responses  of LEW rats immunized with myelin alone 
(Fig.  4). This suppression  was CD8 mediated since in vivo 
depletion of CD8 § cells restored, at least in part, all the re- 
sponses. Treatment with an irrelevant mAb did not modify 
Table  2.  Effect of Transfer of T  Cell Lines on Actively 
Induced EAE 
In vitro  mAb 
Cells transferred  challenge with:  in  vivo  Clinical score 
-  -  -  2,2,3,3,4,4 
LEW  Hg  A  APC  -  0,  0,  0,  0,  0,  0 
LEW  Hg A*  -  -  1,  2,  2,  3,  3 
LEW  Hg A  APC  OX8  1,  2,  3,  3,  3 
LEW  Hg A  APC  B10oH2  1,  0,  0,  0,  0 
LEW  OVA  BP  -  3,  2,  3,  3 
LEW  OVA  OVA  -  3,  4,  2,  4 
APC*  BP  -  2,  2,  3,  4,  4 
APC are syngeneic thymocytes. OX8 is an anti-CD8 mAb; B10-H2 was 
used as an irrelevant  mAb. Calls transferred  were activated for 3 d with 
the appropriate  stimulus. 
* In this culture, LEW Hg A cells were kept for 7 d after  the end of 
stimulation  in medium containing  Con A supernatant  as a source of IL-2. 
t Rats were transferred with thymocytes  incubated with BP (50 #g/ml) 
as a source of myelin-bound APC. 
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Figure  5.  Inhibition of the proliferative response to BP of lymph node 
cells from LEW rats immunized with myelin by various numbers of het- 
erologous lymph node cells. Lymph node cells assessed for suppression 
came from LEW rats immunized with myelin and transferred with the 
LEW Hg A T cell line (.), injected in addition with an anti-CD8 mAb 
([]), or an irrelevant mAb (m), or from rats transferred with the LEW 
OVA T  cell line ([]). 
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jection of LEW OVA cells did not modify the proliferative 
responses  to  BP,  PPD,  Con  A,  or  allogeneic antigens  as 
compared with the responses of  rats immunized with myelin 
alone (Fig 4). 
Lymph node cells from rats transferred with LEW Hg A  Cells 
T cells suppressed in a dose-dependent manner the prolifera-  transferred 
tive responses to BP (Fig. 5) and to PPD (not shown) of  lymph 
node cells from LEW rats immunized with myelin alone.  LEW 
Treatment with the OX8 mAb of LEW rats transferred with  LEW 
LEW Hg A cells inhibited this suppressive effect while treat-  LEW 
ment with the irrelevant B10H2 mAb did not. Lymph node  LEW 
cells from rats transferred with LEW OVA cells had no effect 
LEW  on these aforementioned responses. 
Lymph Node Cells from LEW Hg A  Recipient Rats Recog-  LEW 
nize Activated T Cells.  To assess the specificity of cells from  LEW 
rats transferred with the LEW Hg A T cell line, lymph node  LEW 
cells were cultured in the presence of various stimulus, 21 d  LEW 
after the transfer. They proliferated significantly in the pres- 
ence of the activated LEW Hg A T cell line (p < 0.005) and  LEW 
also, but to a lesser extent, in the presence of the activated  LEW 
LEW OVA T  cell line (p <  0.01), (Table 3), but not in the  LEW 
presence of autologous APC (not shown), when compared  LEW 
with lymph node cells cultured alone. The proliferative re-  LEW 
sponse was greatly reduced when LEW Hg A stimulator cells  LEW 
were not activated, and was abolished when nonactivated LEW  LEW  OVA cells were used (Table 3). LEW spleen cells activated 
by Con A, but not normal spleen cells,  can also  stimulate  LEW 
cells from rats transferred with the LEW Hg A T  cell Iine.  LEW 
Supernatant from Con A-activated spleen cells or from LEW  LEW 
Hg A-activated cells only induced a marginal proliferative  LEW 
response (Table 3).  Lymph node cells from rats transferred 
with the LEW Hg A T  cell line and treated with the anti-  LEW 
CD8 mAb exhibited the same pattern of responses hut with 
much less intensity. Lymph node cells from rats transferred 
with the LEW OVA T cell line responded to activated LEW 
OVA T  cells,  and less to activated LEW Hg A  T  cells or 
resting LEW OVA T  cells,  and not at all to resting LEW 
Hg A  cells.  They did not respond to OVA (not  shown). 
None of the LEW rats transferred with the LEW Hg A 
T  cell line, whether or not they were immunized with my- 
elin and whether or not they were treated with the OX8 
mAb, exhibited an increase in serum IgE concentration or 
renal immune deposits (not shown). These data show that 
the LEW Hg A T  cell line fails to promote autoimmunity. 
Discussion 
This work shows that HgCI2 induces in LEW rats  the 
appearance of anti-class II autoreactive CD4 + T  cells and 
of  antiergotypic  CD8 +  suppressor  cells.  Autoreactive 
anti-class II CD4 + T  cell lines have been derived. One of 
them was transferred that induced CD8 + suppressor T cells 
responsible for a non-antigen-specific suppression and for 
prevention of EAE. 
Autoreactive anti-class II CD4 + T cells are likely respon- 
sible for the autoimmune disease induced by HgCI2 in BN 
rats, as suggested by transfer experiments (19).  The CD4 + 
Table 3.  Proliferative  Responses of Lymph Node Cells from 
Rats Transferred with the LEW Hg A  or the LEW OVA 
T  Cell Line 
Treatment 
with 
anti-CD8  mAb  Stimulus  cpm 
Hg  A  -  -  225  _+  157 
Hg  A  -  LEW Hg A*  17,568  +_  9,236 
Hg A  -  LEW Hg A*  4,790  +_  3,678 
Hg A  -  Sn LEW Hg A  523  _+  145 
Hg  A  -  Sn Con A  986  _+  163 
Hg A  -  LEW nl  722  +  251 
Hg  A  -  LEW nlg  8,892  _+  270 
Hg A  -  LEW OVA*  5,655  _+  2,436 
Hg A  -  LEW OVA*  498  _+  242 
Hg A  +  -  356  _+  175 
Hg A  +  LEW Hg A*  3,442  _+  1,364 
Hg A  +  LEW Hg A*  1,021  +  498 
Hg A  +  Sn LEW Hg A  778  +  298 
Hg A  +  Sn Con A  1,225  +  625 
Hg A  +  LEW OVA*  1,798  _+  293 
Hg A  +  LEW OVA~  512  _+  131 
OVA  -  -  945  _+  198 
OVA  -  LEW Hg A*  3,225  _+  354 
OVA  -  LEW Hg A*  1,045  +  512 
OVA  -  LEW OVA*  8,990  _+  1,693 
OVA  -  LEW OVA*  3,629  _+  355 
Sn, supernatant. 
* Cell lines were activated for 3 d with the appropriate stimulus before 
they were used as stimulator cells. 
* Stimulator cells were used 7 d after the last stimulation. 
S  Stimulator  cells were normal LEW lymph node cells (LEW nl) stimu- 
lated for 2 d with Con A. 
T  cells described here in LEW rats recognized self-class  II 
molecules as in BN rats; their frequency was similar in both 
strains.  Because these CD4 § T cells were unable to promote 
autoimmunity in LEW rats, even when CD8 depleted, they 
probably differ at the functional level from those observed 
in BN rats.  Two different CD4 § T  cell subsets  have been 
described in mice according to the cytokines produced: Thl 
cells  produce IL2 and  IFN-%  and are mainly involved in 
delayed-type hypersensitivity, while Th2 cells produce IL-4, 
IL-5, and IL-10, and are mainly involved in B cell help (20). 
There are convincing arguments supporting a role for Th2 
cells in HgC12-induced autoimmunity in rats (21) and mice 
(22). The autoreactive T cell lines obtained in LEW rats pro- 
duced IL-2 and were unable to help B cells in vitro for Ig 
production, suggesting that they belong to the Thl-like sub- 
type. It has been demonstrated that human Thl clones may 
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pression.  We have verified that  the LEW Hg A T  cell line 
had no  such cytotoxic effect (not  shown). 
The characteristics of our autoreactive lines were very similar 
to those of the autoreactive cells detected in HgC12-injected 
LEW rats.  They were IA but not IE restricted.  In HgC12- 
injected LEW rats, autoreactive T cells and suppressor T cells 
appeared  concomitantly,  and  CD8 +  cells  were  able  to 
proliferate in the presence of autologous CD4 + cells but not 
in the presence of CD8 § cells. The LEW Hg A T  cell line 
also induced,  after transfer,  the appearance  of CD8 + sup- 
pressor cells, which proliferated in the presence of the trans- 
ferred CD4 § line.  In HgC12-injected, as in transferred, rats, 
CD8 + cells were able to downmodulate various T cell func- 
tions and to prevent EAE (7).  One apparent  difference be- 
tween suppression induced by HgC12 or by transfer of the 
LEW Hg A T cell line concerns the appearance of contrasup- 
pressor cells, which were probably responsible for the partial 
protection towards EAE in HgC12-injected LEW rats while 
all the rats transferred with the line were protected. Studies 
are in progress to look for the presence of such cells in rats 
transferred with the LEW Hg A T cell line and to establish 
their  possible connection  with  the suppressor cells. 
The CD8 + suppressor cells induced by the transfer of the 
line or after HgC12 injections proliferated in the presence of 
CD4*  T  cells. In the latter situation,  as reported in another 
system (24), APC were not required; whether APC are im- 
portant or not in the former situation is presently under study. 
Results obtained in rats  transferred  with  the LEW  Hg A 
T cell line showed that lymph node cells from these animals 
recognized far better this T cell line when preactivated. They 
also recognized, although less, the activated, irrelevant, anti- 
OVA T cell line or Con A-activated spleen cells but not resting 
cells. According to Lohse et al. (25), these data demonstrate 
that  the LEW Hg A  T  cell line triggers  CD8 §  antiergo- 
typic cells, defined as cells that recognize a T cell activation 
marker. Therefore, the induction of antiergotypic cells is not 
restricted  to T  cell vaccination  (25).  CDS-depleted lymph 
node cells from rats transferred with the LEW Hg A T cell 
line still proliferated to the same stimuli as undepleted lymph 
node cells, but with much less intensity; this residual prolifer- 
ation  could be  due  to  the  remaining  CD8 +  cells,  or  to 
CD8-  antiergotypic cells (25). LEW Hg A T  cell line-in- 
duced antiergotypic cells did not proliferate either in the pres- 
ence of culture supernatant from activated LEW Hg A cells, 
or from Con A-activated cells, which suggests that these cells 
did not  respond  to lymphokines  only but to a membrane 
antigen. The nature of this antigen remains to be determined. 
It could be an adhesion  molecule (25) or peptides derived 
from the trimolecular complex (class II molecule, TCR, and 
peptide), expressed in the context of class I molecule as pro- 
posed by Janeway (26). The fact that lymph node cells from 
rats transferred with the LEW Hg A T cell line proliferated 
far better in response to activated LEW Hg A cells than to 
the other activated cells tested suggests either that activated 
LEW Hg A  cells are better stimulators  or that  LEW Hg 
A-induced suppressor cells are heterogeneous. This is reminis- 
cent of T  cell vaccination where antiidiotypic (27-32) and, 
to a lesser degree, antiergotypic (25) suppressor T  cells are 
able to protect  against  T  cell-mediated diseases. 
The way the CD8 + suppressor cells act in our model re- 
mains to be determined. A cytotoxic effect on T cells or APC 
is unlikely since lymph node cells from rats transferred with 
the LEW Hg A T  cell line are unable to kill LEW Hg A 
cells, autologous spleen cells, or lymph node cells from normal 
LEW rats immunized with myelin and challenged in vitro 
(not shown). They could interfere with signaling pathways 
of encephalitogenic effector cells (33) or by releasing cytokines 
such as II,-4 (34) or TGF-fl (35). This latter hypothesis could 
explain the non-antigen-specific immunosuppression as shown 
for a suppressor line obtained from a nonobese diabetic mouse 
that was diabetes resistant (36). Works are in progress to ob- 
tain  suppressor T  cell lines  to  answer these questions. 
It has already been reported that anti-class II T cells, able 
to polyclonaUy activate B cells, might trigger the appearance 
of suppressor cells able to suppress immune responses to sev- 
eral exogenous antigens (8). These results, as ours, could be 
explained by the emergence of antiergotypic and/or antiidi- 
otypic cells. It could also explain results concerning the con- 
trol of autoreactive anti-class II T  cells by suppressor cells 
(37-39).  Anti-class II T cells, initially described as a conse- 
quence of an immune response directed against nominal an- 
tigens (40), also exist as normal elements of the immune system 
(37, 39). Anti-class II T  cells activated during an immune 
response would trigger suppressor cells that downmodulate 
in  turn  every  autoreactive  activated  cell,  whatever  their 
specificity.  Thus,  HgC12-induced suppressor cells could rep- 
resent an exacerbation of a physiological process controlling 
autoreactive cells  that  escape tolerance in periphery. 
To seek chemicals that mimic mercury effects in LEW rats 
could be an interesting approach for therapeutics of multiple 
sclerosis  in humans.  Indeed,  this demyelinating  disease,  of 
which EAE is the best experimental model, has been shown 
to be associated with a defect of suppressor inducer cells (41). 
Such  treatments,  by restoring  normal  regulatory  circuits, 
would be more interesting than T cell vaccination since they 
do not require heavy technology, and since they could be ap- 
plied to different autoimmune  diseases. 
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